An Ongoing Role of &agr;-Calcitonin Gene–Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress

&agr;-Calcitonin gene–related peptide (&agr;CGRP) is a vasodilator, but there is limited knowledge of its long-term cardiovascular protective influence. We hypothesized that &agr;CGRP protects against the onset and development of angiotensin II–induced hypertension and have identified protective mechanisms at the vascular level. Wild-type and &agr;CGRP knockout mice that have similar baseline blood pressure were investigated in the angiotensin II hypertension model for 14 and 28 days. &agr;CGRP knockout mice exhibited enhanced hypertension and aortic hypertrophy. &agr;CGRP gene expression was increased in dorsal root ganglia and at the conduit and resistance vessel level of wild-type mice at both time points. &bgr;CGRP gene expression was also observed and shown to be linked to plasma levels of CGRP. Mesenteric artery contractile and relaxant responses in vitro and endothelial NO synthase expression were similar in all groups. The aorta exhibited vascular hypertrophy, increased collagen formation, and oxidant stress markers in response to angiotensin II, with highest effects observed in &agr;CGRP knockout mice. Gene and protein expression of endothelial NO synthase was lacking in the aortae after angiotensin II treatment, especially in &agr;CGRP knockout mice. These results demonstrate the ongoing upregulation of &agr;CGRP at the levels of both conduit and resistance vessels in vascular tissue in a model of hypertension and the direct association of this with protection against aortic vascular hypertrophy and fibrosis. This upregulation is maintained at a time when expression of aortic endothelial NO synthase and antioxidant defense genes have subsided, in keeping with the concept that the protective influence of &agr;CGRP in hypertension may have been previously underestimated.

[1]  T. Koyama,et al.  Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury. , 2013, Journal of molecular and cellular cardiology.

[2]  D. DiPette,et al.  Renal protective effects of α-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension. , 2013, American journal of physiology. Renal physiology.

[3]  L. Gnudi,et al.  A Role for TRPV1 in Influencing the Onset of Cardiovascular Disease in Obesity , 2013, Hypertension.

[4]  Min Zhang,et al.  Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase , 2012, Circulation research.

[5]  Wei-Hua Wu,et al.  Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27. , 2012, European journal of pharmacology.

[6]  S. Brain,et al.  Calcitonin gene-related peptide (CGRP) and its role in hypertension , 2011, Neuropeptides.

[7]  D. Andersson,et al.  4-Oxo-2-nonenal (4-ONE): Evidence of Transient Receptor Potential Ankyrin 1-Dependent and -Independent Nociceptive and Vasoactive Responses In Vivo , 2011, Journal of Pharmacology and Experimental Therapeutics.

[8]  Ting-ting Li,et al.  Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression. , 2010, Atherosclerosis.

[9]  F. Faraci,et al.  Receptor Activity-Modifying Protein-1 Augments Cerebrovascular Responses to Calcitonin Gene-Related Peptide and Inhibits Angiotensin II-Induced Vascular Dysfunction , 2010, Stroke.

[10]  A. Shah,et al.  Oxidative Stress and Endothelial Dysfunction in Aortas of Aged Spontaneously Hypertensive Rats by NOX1/2 Is Reversed by NADPH Oxidase Inhibition , 2010, Hypertension.

[11]  Dachun Yang,et al.  Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. , 2010, Cell metabolism.

[12]  C. Lines,et al.  Randomized, controlled trial of telcagepant over four migraine attacks , 2010, Cephalalgia : an international journal of headache.

[13]  F. Abboud,et al.  Receptor Activity–Modifying Protein 1 Increases Baroreflex Sensitivity and Attenuates Angiotensin-Induced Hypertension , 2010, Hypertension.

[14]  O. Carretero,et al.  Lack of Glutathione Peroxidase 1 Accelerates Cardiac-Specific Hypertrophy and Dysfunction in Angiotensin II Hypertension , 2010, Hypertension.

[15]  A. Shah,et al.  Protection of Angiotensin II–Induced Vascular Hypertrophy in Vascular Smooth Muscle–Targeted Receptor Activity-Modifying Protein 2 Transgenic Mice , 2009, Hypertension.

[16]  D. Luo,et al.  Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats , 2008, Peptides.

[17]  A. Shepard,et al.  Nox4 Oxidase Overexpression Specifically Decreases Endogenous Nox4 mRNA and Inhibits Angiotensin II–Induced Adventitial Myofibroblast Migration , 2008, Hypertension.

[18]  A. Shah,et al.  A reactive oxygen species-mediated component in neurogenic vasodilatation. , 2008, Cardiovascular research.

[19]  F. Faraci,et al.  Glutathione Peroxidase-1 Plays a Major Role in Protecting Against Angiotensin II–Induced Vascular Dysfunction , 2008, Hypertension.

[20]  Ruiping Huang,et al.  Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury. , 2008, American journal of physiology. Heart and circulatory physiology.

[21]  D. Stec,et al.  HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  C. Somasundaram,et al.  Adventitial Neuronal Somata , 2006, Journal of Vascular Research.

[23]  K. Katki,et al.  Role of Calcitonin Gene-Related Peptide in Hypertension-Induced Renal Damage , 2005, Hypertension.

[24]  E. Pintér,et al.  An examination of neurogenic mechanisms involved in mustard oil-induced inflammation in the mouse. , 2005, European journal of pharmacology.

[25]  Donna H. Wang,et al.  Development of angiotensin II-induced hypertension: role of CGRP and its receptor , 2005, Journal of hypertension.

[26]  Xian Wang,et al.  Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta. , 2004, American journal of physiology. Heart and circulatory physiology.

[27]  L. Chau,et al.  Heme Oxygenase-1 Inhibits Angiotensin II–Induced Cardiac Hypertrophy In Vitro and In Vivo , 2004, Circulation.

[28]  S. Brain,et al.  Vascular actions of calcitonin gene-related peptide and adrenomedullin. , 2004, Physiological reviews.

[29]  D. Liao,et al.  Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells. , 2004, European journal of pharmacology.

[30]  J. Olesen,et al.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. , 2004, The New England journal of medicine.

[31]  A. Zalewski,et al.  Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[32]  J. Sanes,et al.  Mice Lacking α-Calcitonin Gene-Related Peptide Exhibit Normal Cardiovascular Regulation and Neuromuscular Development , 1999, Molecular and Cellular Neuroscience.

[33]  J. Changeux,et al.  Modulation of morphine analgesia in αcgrp mutant mice , 1999 .

[34]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[35]  P. Brecher,et al.  Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. , 1998, Circulation research.

[36]  A. Fujimori,et al.  Enhanced Depressor and Hyperemic Responses to Calcitonin Gene-related Peptide in Spontaneously Hypertensive Rats , 1998, Peptides.

[37]  X. Wang,et al.  The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells , 1997, Neuropeptides.

[38]  D. DiPette,et al.  Regulation of neuronal calcitonin gene-related peptide expression. Role of increased blood pressure. , 1995, Hypertension.

[39]  F. Portaluppi,et al.  Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man. , 1993, The Journal of clinical endocrinology and metabolism.

[40]  H. Kishimoto,et al.  The antihypertensive effect of calcitonin gene-related peptide in rats with norepinephrine- and angiotensin II-induced hypertension. , 1991, Journal of Hypertension.

[41]  A. Haegerstrand,et al.  Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Längle,et al.  Plasma CGRP in acute myocardial infarction , 1990, The Lancet.

[43]  H. Morris,et al.  Calcitonin gene-related peptide is a potent vasodilator , 1985, Nature.

[44]  M. Mulvany,et al.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. , 1977, Circulation research.

[45]  Tamara,et al.  NADPH Oxidases, Reactive Oxygen Species, and Hypertension Clinical implications and therapeutic possibilities , 2008 .

[46]  D. Harrison,et al.  Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. , 2005, American journal of physiology. Heart and circulatory physiology.

[47]  K. Westlund,et al.  Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. , 2000, Hypertension.

[48]  K. Westlund,et al.  Increased Blood Pressure in α-Calcitonin Gene–Related Peptide/Calcitonin Gene Knockout Mice , 2000 .

[49]  J. Changeux,et al.  Modulation of morphine analgesia in alphaCGRP mutant mice. , 1999, Neuroreport.